Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha. (Q53370639)

13 May 2018

title

Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha. (English)

1 reference

13 May 2018

0 references

1 reference

1 reference

9

Shixuan Wang

1 reference

13 May 2018

author name string

Lei Huang

1

1 reference

13 May 2018

Qilin Ao

2

1 reference

13 May 2018

Qinghua Zhang

3

1 reference

13 May 2018

Xiaokui Yang

4

1 reference

13 May 2018

Hui Xing

5

1 reference

13 May 2018

Fang Li

6

1 reference

13 May 2018

Gang Chen

7

1 reference

13 May 2018

Jianfeng Zhou

8

1 reference

13 May 2018

Gang Xu

10

1 reference

13 May 2018

Li Meng

11

1 reference

13 May 2018

Yunping Lu

12

1 reference

13 May 2018

Ding Ma

13

1 reference

13 May 2018

publication date

16 September 2009

1 reference

13 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

13 May 2018

volume

136

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

447-456

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-009-0675-4

exact match

0 references

cites work

Tumor microenvironment and the response to anticancer therapy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0675-4

Hypoxic suppression of the cell cycle gene CDC25A in tumor cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0675-4

Small molecule-mediated anti-cancer therapy via hypoxia-inducible factor-1 blockade

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0675-4

Resistance to chemotherapy in ovarian carcinoma.

21 January 2018

1 reference

12 December 2020

[The impact of the pathologist on the treatment of epithelial ovarial cancer]

1 reference

12 December 2020

YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

1 reference

12 December 2020

Drug resistance mediated by cellular stress response to the microenvironment of solid tumors

1 reference

12 December 2020

Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer

1 reference

12 December 2020

Hypoxia-inducible factor 1 (HIF-1) pathway

1 reference

12 December 2020

Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis

1 reference

12 December 2020

Dynamic balancing of the dual nature of HIF-1alpha for cell survival

1 reference

12 December 2020

Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage

1 reference

12 December 2020

The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.

1 reference

12 December 2020

Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia

1 reference

12 December 2020

Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

1 reference

12 December 2020

Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer.

1 reference

12 December 2020

[Epithelial ovarian cancer]

1 reference

12 December 2020

Targeting HIF-1 for cancer therapy

1 reference

12 December 2020

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

1 reference

12 December 2020

Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an ind

1 reference

12 December 2020

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

12 December 2020

YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia

1 reference

12 December 2020

Hypoxia, HIF-1, and the pathophysiology of common human diseases.

1 reference

12 December 2020

Hypoxia-inducible factor-1alpha induces cell cycle arrest of endothelial cells.

1 reference

12 December 2020

Involvement of hypoxia-inducible factor 1 in human cancer

1 reference

12 December 2020

Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids

1 reference

12 December 2020

A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology

1 reference

12 December 2020

Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells

1 reference

12 December 2020

HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

1 reference

12 December 2020

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha

1 reference

12 December 2020

Hypoxia inhibits G1/S transition through regulation of p27 expression

1 reference

12 December 2020

Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma

1 reference

12 December 2020

Analysis of hypoxia-inducible factor 1alpha expression and its effects on invasion and metastasis.

1 reference

12 December 2020

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

1 reference

12 December 2020

HIF-1 and tumor progression: pathophysiology and therapeutics

1 reference

12 December 2020

Targeting topoisomerase I to inhibit hypoxia inducible factor 1.

1 reference

12 December 2020

Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.

1 reference

12 December 2020

Identification of nonproliferating but viable hypoxic tumor cells in vivo.

1 reference

12 December 2020

10.1007/S00432-009-0675-4

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018